Showing results (251-260 of 1,352) with videos related to

Sort By:
Pageof 136
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: coronary artery stents - past, present and futureGiulio G Stefanini, Robert A Byrne, Stephan Windecker, et al.
Circulation. Cardiovascular Interventions|February 7, 2015
Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantationCrochan J O'Sullivan, Stefan Stortecky, Anne Bütikofer, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarctionChristoph Gräni, Anselm W Stark, Kady Fischer, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trialThomas Pilgrim, Lorenz Räber, Andreas Limacher, et al.
Circulation. Cardiovascular Interventions|March 30, 2012
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stentsThomas Pilgrim, Florian Vetterli, Bindu Kalesan, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 5, 2015
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillationSteffen Gloekler, Samera Shakir, Janosch Doblies, et al.
Lancet (London, England)|September 2, 2018
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trialThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.
JACC. Cardiovascular Interventions|August 19, 2019
Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical PracticeChristian Zanchin, Yasushi Ueki, Thomas Zanchin, et al.
Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.
Pageof 136